TickerFactsScreenerDevelopers

CytomX Therapeutics, Inc. (CTMX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $732.0K2014: $1.66M2015: $1.59M2016: $2.18M2017: $1.56M2018: $3.79M2019: $3.50M2020: $2.31M2021: $1.61M2022: $1.74M2023: $840.0K2024: $310.0K2025: $220.0K$220.0K
2013Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$220.0K-29.0%
2024$310.0K-63.1%
2023$840.0K-51.7%
2022$1.74M+8.1%
2021$1.61M-30.3%
2020$2.31M-34.0%
2019$3.50M-7.7%
2018$3.79M+143.0%
2017$1.56M-28.4%
2016$2.18M+36.5%
2015$1.59M-4.1%
2014$1.66M+127.2%
2013$732.0K—